5 documents found, page 1 of 1
Why don’t we consume energy more efficiently?
Barreto, Ana margarida; Brito, Nuno Correia; Boechat, Anna carolina; Oliveira martins, Luís; Martins, FernandoUIDB/05021/2020 UIDP/05021/2020; Introduction: Almost 50% of the European Union’s final energy consumption is used for heating and cooling, 80% of which in buildings. The European Commission recently issued the “Efficiency Energy First Principle,” a formal recommendation to EU countries prioritizing energy efficiency measures over other energy-related investments. Decarbonizing the aging housing stock represent...
Reuma.pt/vasculitis - the Portuguese vasculitis registry
Ponte, Cristina; Khmelinskii, Nikita; Teixeira, Vítor; Luz, Karine; Peixoto, Daniela; Rodrigues, Marília; Luís, Mariana; Teixeira, Lídia; Sousa, SandraBACKGROUND: The vasculitides are a group of rare diseases with different manifestations and outcomes. New therapeutic options have led to the need for long-term registries. The Rheumatic Diseases Portuguese Register, Reuma.pt, is a web-based electronic clinical record, created in 2008, which currently includes specific modules for 12 diseases and > 20,000 patients registered from 79 rheumatology centres. On Oct...
Genetic Predictors of Poor Prognosis in Portuguese Patients with Juvenile Idiop...
Mourão, Ana Filipa; Santos, Maria José; Mendonça, Sílvia; Oliveira-Ramos, Filipa; Salgado, Manuel; Estanqueiro, Paula; Melo-Gomes, JoséIntroduction. This study aimed to assess the genetic determinants of poor outcome in Portuguese patients with juvenile idiopathic arthritis (JIA). Methods. Our study was conducted in Reuma.pt, the Rheumatic Diseases Portuguese Register, which includes patients with JIA. We collected prospectively patient and disease characteristics and a blood sample for DNA analysis. Poor prognosis was defined as CHAQ/HAQ >0.7...
Comparative effectiveness and predictors of response to tumour necrosis factor ...
Canhão, Helena; Maria Rodrigues, Ana; Mourão, Ana Filipa; Martins, Fernando; Santos, Maria José; Canas-silva, José; Polido-pereira, JoaquimFunding Information: positions on two Pfizer sponsored trials and has directed an educational course supported by Bristol Myers Squibb. He serves as an epidemiology consultant to CORRONA. J.A.P.S. has received honoraria as a speaker or consultant and benefited from research support from several pharmaceutical companies involved in the production of biologic agents (Abbott, Amgen, MSD, Pfizer and Roche), always ...
Reuma. PT - the rheumatic diseases portuguese register
Canhão, Helena; Faustino, Augusto; Martins, Fernando; Fonseca, João Eurico; Nero, Patrícia; Branco, JaimeReuma.pt is supported by unrestricted research grants from Abbott, Bristol Myers Squibb, Merck Sharp and Dohme, Pfizer, Roche and UCB Pharma. HC received a grant from Fundacao para a Ciencia e Tecnologia (FCT), Harvard Medical School-Portugal Program, HMSP-ICS/SAU-ICT/0002/2010.; Introduction: Since June 2008, Portuguese rheu -matologists have been collecting on a routine basis, data into the nationwide Reuma.p...